CoreCap Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $495 | Sell |
9
-5,262
| -100% | -$289K | ﹤0.01% | 2502 |
|
|
2025
Q1 | $373K | Buy |
5,271
+5,255
| +32,844% | +$371K | 0.02% | 532 |
|
|
2024
Q4 | $1.05K | Buy |
16
+7
| +78% | +$460 | ﹤0.01% | 2366 |
|
|
2024
Q3 | $633 | Hold |
9
| – | – | ﹤0.01% | 2332 |
|
|
2024
Q2 | $741 | Hold |
9
| – | – | ﹤0.01% | 1414 |
|
|
2024
Q1 | $786 | Buy |
+9
| New | +$786 | ﹤0.01% | 2264 |
|
|
2022
Q4 | $19.8K | Sell |
191
-17,741
| -99% | -$1.84M | ﹤0.01% | 1309 |
|
|
2022
Q3 | $1.52M | Buy |
17,932
+17,847
| +20,996% | +$1.51M | 0.13% | 145 |
|
|
2022
Q2 | $7K | Buy |
+85
| New | +$7K | ﹤0.01% | 1555 |
|
|
2022
Q1 | – | Sell |
-100
| Closed | -$9K | – | 728 |
|
|
2021
Q4 | $9K | Buy |
+100
| New | +$9K | ﹤0.01% | 1572 |
|